Omalizumab in the treatment of chronic spontaneous urticaria – literature review and own experience
Chronic urticaria is a condition characterized by the appearance of wheals and/or angioedema that last for at least 6 weeks. According to the recent recommendations, if H1-antihistamines used in four times licensed doses remain ineffective, add-on treatment with omalizumab, cyclosporine A or montelu...
Main Authors: | Joanna Dawicka, Aleksandra Wilkowska, Elżbieta Grubska-Suchanek, Roman Nowicki |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2016-02-01
|
Series: | Przegląd Dermatologiczny |
Subjects: | |
Online Access: | https://www.termedia.pl/Omalizumab-in-the-treatment-of-chronic-spontaneous-urticaria-literature-review-and-own-experience,56,26911,1,1.html |
Similar Items
-
Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
by: Murat Türk, et al.
Published: (2018-01-01) -
Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012-01-01) -
Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn’s Disease
by: Simona Barni, et al.
Published: (2021-03-01) -
Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
by: Kiran Godse, et al.
Published: (2016-01-01) -
Role of omalizumab in refractory chronic spontaneous urticaria: A single referral center experience
by: Gautam Kumar Singh, et al.
Published: (2018-01-01)